BASF (XTRA:BAS) Could Be 1% Overvalued As Packaging And Ammonia Tailwinds Build

Recent industry reports on sustainable bioplastics and ammonia markets have put BASF (XTRA:BAS) in focus, highlighting its compostable packaging portfolio and role as a major ammonia producer amid changing regulations and evolving demand.

Against this backdrop, BASF’s share price of €52.98 comes after a 30 day share price return of 5.12% and an 18.31% year to date share price return, while a total shareholder return of 21.91% over the past year hints that sentiment has been improving rather than fading.

The recent move to €52.98 and a strong 1-year total return leaves BASF looking less discounted than before. Is it worth stepping in at this level, or does it pay to wait for a cheaper entry as valuation stacks up next?

Most Popular Narrative: 1% Overvalued

The most followed BASF narrative points to a fair value of about €52.55, which sits just below the latest close at €52.98. That small gap frames the story as finely balanced rather than deeply mispriced.

Significant cost-savings programs (targeting €2.1 billion annual savings by end of 2026), alongside the completion of the major China Verbund investment (with project costs under budget and CapEx falling below depreciation from 2026), will meaningfully improve operating leverage and free cash flow, with cost competitiveness directly supporting improved net margins.

Read the complete narrative. Read the complete narrative.

The fair value call leans on a specific playbook. It combines modest revenue growth, firmer margins and a P/E that steps down from today’s level. It highlights which assumptions carry the most weight in that mix and how they balance against the planned China build out and cost savings path.

Result: Fair Value of €52.55 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, BASF still faces risks if global base chemicals overcapacity lingers, or if European restructuring and potential asset closures drag more heavily on cash flow.

Find out about the key risks to this BASF narrative.

Another View on BASF Valuation

The analyst narrative suggests BASF is about 1% overvalued around €52.98. Our DCF model points in a different direction. It values BASF’s future cash flows at about €106.20 per share, which is roughly double the current price and presents the stock as materially undervalued.

This gap between an overvalued assessment based on earnings multiples and a large DCF upside raises a clear question for investors. Which set of assumptions appears more realistic for BASF’s long term cash generation and risk profile, and how much weight should each method carry in your process?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out BASF for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 262 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the mixed signals around BASF leave you undecided, that is a useful cue to review the numbers yourself and move quickly while sentiment is still forming. To weigh up the balance of concerns and potential upsides, start with a clear view of the 3 key rewards and 3 important warning signs.

Looking for more BASF style investment ideas?

If BASF has sharpened your interest in materials, chemicals and income, do not stop here. The next opportunities could be sitting just outside your current watchlist.

• Target reliable cash generators and compare them against 262 high quality undervalued stocks that combine quality fundamentals with appealing prices.
• Prioritise income by reviewing the 413 dividend fortresses that focus on higher yielding companies with resilient profiles.
• Sleep easier by checking the 298 resilient stocks with low risk scores designed to surface companies with steadier risk scores and stronger balance sheets.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com